Impact of genetic polymorphisms in the interleukin-18 and interleukin-21 genes on the risk and clinical outcomes of multiple sclerosis

• by Noha M. Bakr, Noha A. Hashim, Mohamed Adel El-Eshmawy, Hatim A. El-Baz

• May 25, 2026

Genetic-Proteomic Integration Identifies Predictive Plasma Proteins for Multiple Sclerosis

• by Yuan Ding, Dylan Hamitouche, Simon Thebault, Patrick Kearns, Ahmed Abdelhak, Adil Harroud

• May 22, 2026

Now Enrolling: Real-World Registry Study of BRUMVI (Ublituximab-xiiy) in Relapsing Multiple Sclerosis

Baptist Health Brain & Spine Care is enrolling patients with confirmed multiple sclerosis who are starting BRUMVI to track outcomes, safety, and patient experience over time in a real-world setting.

• March 4, 2026

• 2 min

Inflammatory CADASIL: the cross-link between CADASIL and multiple sclerosis: a report of two cases and systematic review of the literature

• by Ali Mahmoud Ahmed, Niraj Mistry, Ahmed Samir Gehad, Abdelmonem M. Hassan

• June 5, 2026